日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers

AZD6422(一种靶向CLDN18.2的嵌合抗原受体T细胞)在胃癌、胰腺癌和食管癌中的临床前评估

Allison M Barrett ,Zachary T Britton ,Rosa A Carrasco ,Shannon Breen ,Maria A S Broggi ,Amanda L Hatke ,Benjamin Clark ,Chunning Yang ,Sandrina Phipps ,Lorenzo Ortiz ,Brianna Janocha ,Peter Zanvit ,Nicolas A Giraldo ,Philip L Martin ,Jean-Martin Lapointe ,Nathalie Harder ,Georgina H Cornish ,Bala N N R Attili ,Yariv Mazor ,Melissa Damschroder ,Mark Cobbold ,Gordon Moody ,Emily E Bosco

Methylene Blue Preserves Cytochrome Oxidase Activity and Prevents Neurodegeneration and Memory Impairment in Rats With Chronic Cerebral Hypoperfusion

亚甲蓝可维持细胞色素氧化酶活性,并预防慢性脑低灌注大鼠的神经退行性变和记忆障碍。

Auchter, Allison M; Barrett, Douglas W; Monfils, Marie H; Gonzalez-Lima, F

Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers

使用 DNA 损伤标记物评估癌症治疗剂的药效学反应

Deborah F Wilsker, Allison M Barrett, Angie B Dull, Scott M Lawrence, Melinda G Hollingshead, Alice Chen, Shivaani Kummar, Ralph E Parchment, James H Doroshow, Robert J Kinders